Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders

European Journal of Haematology

Volumn 80, Issue 6, 2008, Pages 540-544

  Kunishima, Shinji ^a   Matsushita, Tadashi ^b   Hamaguchi, Motohiro ^a   Saito, Hidehiko ^c  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA CENTRAL HOSPITAL   (Japan)

Author keywords

Alu elements; Gene deletion; Macrothrombocytopenia; MYH9 disorders

Indexed keywords

GENOMIC DNA; MESSENGER RNA; NUCLEOTIDE; PROTEIN;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CELL INCLUSION; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; IMMUNOBLOTTING; LEUKOCYTE; MALE; MYH9 GENE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THROMBOCYTE; THROMBOCYTOPENIA;

ADULT; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; GENE DELETION; HUMANS; MALE; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; THROMBOCYTOPENIA;

EID: 43549084398     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01046.x     Document Type: Article

References (18)

1. May R. Leukozyteneinschlusse. Dtsch Arch Klin Med 1909 96: 1 6.
2. Hegglin R. Gleichzeitige konstitutionelle Veranderungen an Neutrophilen und Thrombocyten. Helv Med Acta 1945 12: 439 40.
3. Saito H, Kunishima S. Historical hematology: May-Hegglin anomaly. Am J Hematol 2008 83: 304 6.
4. Seri M, Cusano R, Gangarossa S, et al. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium. Nat Genet 2000 26: 103 5.
5. Kelley MJ, Jawien W, Ortel TL, Korczak JF. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000 26: 106 8.
6. Kunishima S, Kojima T, Matsushita T, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 2001 97: 1147 9.
7. Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001 69: 1033 45.
8. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001 46: 722 9.
9. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003 82:203 15.
10. Dong F, Li S, Pujol-Moix N, Luban NL, Shin SW, Seo JH, Ruiz-Saez A, Demeter J, Langdon S, Kelley MJ. Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br J Haematol 2005 130:620 7.
11. Pecci A, Panza E, Pujol-Moix N, et al. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat 2008 29:409 17.
12. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, Inoue C, Kamiya T, Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 2003 83:115 22.
13. Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN. Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination-associated motifs. Hum Mutat 2003 22:229 44.
14. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006 7:85 97.
15. Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab 1999 67:183 93.
16. Kunishima S, Hamaguchi M, Saito H. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders. Blood in press.
17. Deutsch S, Rideau A, Bochaton-Piallat ML, Merla G, Geinoz A, Gabbiani G, Schwede T, Matthes T, Antonarakis SE, Beris P. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome. Blood 2003 102:529 34.
18. Pecci A, Canobbio I, Balduini A, Stefanini L, Cisterna B, Marseglia C, Noris P, Savoia A, Balduini CL, Torti M. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations. Hum Mol Genet 2005 14:3169 78.